Daily BriefsEvent-Driven

Daily Brief Event-Driven: EOFlow/Medtronic: What Lawsuit? and more

In today’s briefing:

  • EOFlow/Medtronic: What Lawsuit?
  • Korea – Positioning in Ecopro, JYP Entertainment, Hanwha Ocean, Hanmi Semi, CJ Corp, E-Mart
  • Golden Eagle Retail (3308 HK): Scheme Vote on 15 September
  • M&A Research Institute Holdings (9552) TOPIX Inclusion
  • EOFLOW/Medtronic Tender: Irrational Exuberance
  • Quiddity Leaderboard F100/​​​250 Sep 23: Several Changes Including Potential Surprises


EOFlow/Medtronic: What Lawsuit?

By David Blennerhassett

  • On the 8th of August, Insulet Corp (PODD US) filed a lawsuit accusing Eoflow (294090 KS) of the misappropriation of trade secrets, patent infringement, and trademark dilution.
  • The filing was pretty heavy on accusations. EOFlow declined ~11% on the news.
  • Undeterred, Medtronic (MDT US) continues to preach all is peachy, suggesting the EOFlow merger is a go, and Medtronic will deal with the lawsuit, as and when.

Korea – Positioning in Ecopro, JYP Entertainment, Hanwha Ocean, Hanmi Semi, CJ Corp, E-Mart

By Brian Freitas


Golden Eagle Retail (3308 HK): Scheme Vote on 15 September

By Arun George

  • Golden Eagle Retail (3308 HK)‘s scheme document is out, with the court meeting scheduled for 15 September. The IFA considers the HK$6.88 per share offer fair and reasonable. 
  • The key condition is approval by at least 75% of disinterested shareholders (<10% of all disinterested shareholders rejection). The shareholder with a blocking stake has provided an irrevocable.
  • This is a done deal which help by the material derating of peers. At the current price of HK$6.75 and for the 17 October payment, the gross/annualised spread is 1.9%/13.4%.

M&A Research Institute Holdings (9552) TOPIX Inclusion

By Travis Lundy

  • Yesterday, M&A Research Institute (9552 JP) announced it would list on the TSE Prime section on 29 August, which means it will join TOPIX at the close of 28-Sep-2023.
  • This is NOT a surprise. On 27 June, the company announced a secondary offering of 1.631mm shares (by the founder/CEO), and said it had applied for TSE Prime transfer. 
  • I take a look at how this could play out. 

EOFLOW/Medtronic Tender: Irrational Exuberance

By Arun George

  • Eoflow (294090 KS) shares were up 4.4% on the back of Medtronic Plc (MDT US)’s earnings call comment that it expects the acquisition to close at the end of 2023.
  • The bear view is that Medtronic’s messaging remained unchanged as it is still assessing Insulet Corp (PODD US) lawsuit and the potential impact on the timing and/or pricing.
  • The bull view is that Medtronic’s comment underscores its commitment to close the transaction. It’s tough to take a call on risk/reward profile – at best it’s a brave buy. 

Quiddity Leaderboard F100/​​​250 Sep 23: Several Changes Including Potential Surprises

By Janaghan Jeyakumar, CFA

  • In this insight, we take a look at the potential index changes for F100 and F250 in the run up to the September 2023 Rebalance.
  • I expect four changes for F100 and seven changes for F250 based on the latest available data.
  • However, with five more trading days left for the base date and with many names lurking close to the border, the rankings can still change.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars